Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice.
暂无分享,去创建一个
[1] P. Angulo,et al. Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.
[2] G. Gores,et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. , 2003, Gastroenterology.
[3] R. Fisher,et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.
[4] Judy Lieberman,et al. RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.
[5] G. Gores,et al. Cholestasis Increases Tumor Necrosis Factor-Related Apoptotis-Inducing Ligand (TRAIL)-R2/DR5 Expression and Sensitizes the Liver to TRAIL-Mediated Cytotoxicity , 2002, Journal of Pharmacology and Experimental Therapeutics.
[6] G. Gores,et al. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. , 2002, Gastroenterology.
[7] S. Friedman,et al. Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice , 2002, Hepatology.
[8] K. Lindor,et al. Non‐alcoholic fatty liver disease , 2002, Journal of gastroenterology and hepatology.
[9] R. Karim,et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.
[10] J. Maher,et al. Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[11] G. Gores,et al. The Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis* , 2001, The Journal of Biological Chemistry.
[12] Y. Takei,et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals , 2001, Hepatology.
[13] G. Marchesini,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.
[14] G. Ciliberto,et al. Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL* , 2001, The Journal of Biological Chemistry.
[15] G. Farrell,et al. Etiopathogenesis of Nonalcoholic Steatohepatitis , 2001, Seminars in liver disease.
[16] G. Marchesini,et al. Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes , 2001, Seminars in liver disease.
[17] A. Diehl,et al. Animal Models of Steatosis , 2001, Seminars in liver disease.
[18] J. Friedman,et al. Obesity in the new millennium , 2000, Nature.
[19] K. Batts,et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.
[20] M. Thun,et al. Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.
[21] G. Gores,et al. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. , 1999, Gastroenterology.
[22] Z. Younossi,et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.
[23] G. Gores,et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.
[24] S. Nagata,et al. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand , 1998, Nature Medicine.
[25] L. Kaplan. Leptin, obesity, and liver disease. , 1998, Gastroenterology.
[26] H. Jaeschke,et al. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and fas‐antibody–induced liver injury , 1998, Hepatology.
[27] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[28] G. Gores,et al. Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes. , 1995, The American journal of physiology.
[29] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: an expanded clinical entity. , 1994, Gastroenterology.
[30] L. Groop,et al. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. , 1991, The Journal of clinical investigation.
[31] R. DeFronzo,et al. Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.
[32] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.